Fernandez Andre J reported grant involving 2,200 derivative units of Cardlytics, Inc. at $0.00 for $0 on May 20, 2026

Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
Director
DIR
Filed Aug 24, 2026

Facts from the filing

Form 4/A · Derivative, table II
Disclosed value
$0Shares × reported price
Shares traded
2,200Restricted Stock Units
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
2,200Direct
Trade date
May 20, 2026Grant
Filed
Aug 24, 2026, 4:04 PM ET96-day reporting delay
Accession
0001628280-26-058613Code A · Transaction 83469
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

This amendment is separate from the original filing. It may contain only changed rows. Read both SEC reports.

Filing warnings

Notes recorded with this filing
2 warnings
amended filingThis transaction comes from an amended Form 4 filing.
delayed filingThe filing was reported 96 calendar days after the transaction date.

CDLX price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
CDLX · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago −77%1w ago −79%1d ago −79%
Returns since7d −5.8%30d −16%90d180d1y

Footnotes in full

F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. F2: On May 21, 2026, the reporting person filed a Form 4 which inadvertently reported an incorrect number of shares underlying the RSU awarded to the reporting person. As reported in this amendment, the reporting person was awarded RSUs representing a right to receive 2,200 shares of the Issuer's common stock. The number of securities reported within this footnote have been adjusted to reflect the 1-for-10 reverse stock split of the Issuer's common stock, which was effective June 5, 2026. F3: The RSUs shall vest in full on the one-year anniversary of the date of grant, provided that the Reporting Person remains a director of the Issuer on such vesting date.